A better understanding of JAK/STAT pathway activation for the occurrence and development of rheumatoid arthritis will allow the deepening of strategies and therapeutic targets and the development of JAK inhibitor antirheumatic drugs. Here, SOAT1 is linked to rheumatoid arthritis.